newsfilter
← Latest News
Business Wire·

NovaBay Pharmaceuticals Reports First Quarter 2024 Financial Results

Net product sales increased 13% over the prior year driven by higher sales of Avenova®-branded products through OTC channels and branded wound care products Sales and marketing expenses declined 15% reflecting